Mark Shapiro
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 18
- Chronic Myeloid Leukemia Treatments 16
- Oncology 14
- CAR-T cell therapy research 3
- Co-authors
- Juan P. Wisnivesky (5 shared papers)Cynthia Chin (5 shared papers)Steven Swanson (4 shared papers)Todd S. Weiser (4 shared papers)Jörge E. Cortes (12 shared papers)Shubin Sheng (1 shared paper)Robert J. Korst (3 shared papers)Cameron D. Wright (1 shared paper)
- Journals
- Blood (9 papers)Journal of Clinical Oncology (7 papers)The Annals of Thoracic Surgery (3 papers)British Journal of Cancer (2 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Mark Shapiro
45 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 87
- Hematology 349
- Genetics 267
- Oncology 398
- Pulmonary and Respiratory Medicine 462
- Microbiology 11
Countries citing papers authored by Mark Shapiro
This map shows the geographic impact of Mark Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shapiro more than expected).
Fields of papers citing papers by Mark Shapiro
This network shows the impact of papers produced by Mark Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shapiro. The network helps show where Mark Shapiro may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 272 | |
| 2 | 2010 | 163 | |
| 3 | 2009 | 118 | |
| 4 | 2011 | 88 | |
| 5 | 2016 | 70 | |
| 6 | 2013 | 64 | |
| 7 | 2015 | 61 | |
| 8 | 2015 | 57 | |
| 9 | 1953 | 50 | |
| 10 | 2018 | 46 | |
| 11 | 2012 | 44 | |
| 12 | 2015 | 33 | |
| 13 | 2016 | 33 | |
| 14 | 2008 | 31 | |
| 15 | 2014 | 29 | |
| 16 | 2008 | 29 | |
| 17 | 2008 | 26 | |
| 18 | 2012 | 26 | |
| 19 | 2006 | 24 | |
| 20 | 2016 | 23 |
About Mark Shapiro
Mark Shapiro is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Surgery, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (12 papers), Lung Cancer Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (349 citations), Genetics (267 citations), Oncology (398 citations), Pulmonary and Respiratory Medicine (462 citations) and Microbiology (11 citations). Mark Shapiro has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Juan P. Wisnivesky, Cynthia Chin, Steven Swanson, Todd S. Weiser, Jörge E. Cortes, Shubin Sheng, Robert J. Korst, Cameron D. Wright, Hagop M. Kantarjian and Tim H. Brümmendorf. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Annals of Thoracic Surgery, British Journal of Cancer and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.